Cargando…

BIITE: A Tool to Determine HLA Class II Epitopes from T Cell ELISpot Data

Activation of CD4(+) T cells requires the recognition of peptides that are presented by HLA class II molecules and can be assessed experimentally using the ELISpot assay. However, even given an individual’s HLA class II genotype, identifying which class II molecule is responsible for a positive ELIS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boelen, Lies, O’Neill, Patrick K., Quigley, Kathryn J., Reynolds, Catherine J., Maillere, Bernard, Robinson, John H., Lertmemongkolchai, Ganjana, Altmann, Daniel M., Boyton, Rosemary J., Asquith, Becca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783075/ https://www.ncbi.nlm.nih.gov/pubmed/26953935 http://dx.doi.org/10.1371/journal.pcbi.1004796

Ejemplares similares

Immune Control of Burkholderia pseudomallei––Common, High-Frequency T-Cell Responses to a Broad Repertoire of Immunoprevalent Epitopes
por: Nithichanon, Arnone, et al.
Publicado: (2018)

The serodominant secreted effector protein of Salmonella, SseB, is a strong CD4 antigen containing an immunodominant epitope presented by diverse HLA class II alleles
por: Reynolds, Catherine J, et al.
Publicado: (2014)

Identifying the immune interactions underlying HLA class I disease associations
por: Debebe, Bisrat J, et al.
Publicado: (2020)

T Cell Immunity to the Alkyl Hydroperoxide Reductase of Burkholderia pseudomallei: A Correlate of Disease Outcome in Acute Melioidosis
por: Reynolds, Catherine, et al.
Publicado: (2015)

Human NK cell receptor KIR2DS4 detects a conserved bacterial epitope presented by HLA-C
por: Sim, Malcolm J. W., et al.
Publicado: (2019)

Multiplexed gene expression analysis of HLA class II-associated podoconiosis implicates chronic immune activation in its pathogenesis
por: Alcantara, Diana R, et al.
Publicado: (2020)

HIV-1 adaptation to NK cell-mediated immune pressure
por: Elemans, Marjet, et al.
Publicado: (2017)

The relative contributions of infectious and mitotic spread to HTLV-1 persistence
por: Laydon, Daniel J., et al.
Publicado: (2020)

CD4+ T Cells Targeting Dominant and Cryptic Epitopes from Bacillus anthracis Lethal Factor
por: Ascough, Stephanie, et al.
Publicado: (2016)

Autoantigen cross-reactive environmental antigen can trigger multiple sclerosis-like disease
por: Reynolds, Catherine J, et al.
Publicado: (2015)

T cell immunity to Zika virus targets immunodominant epitopes that show cross-reactivity with other Flaviviruses
por: Reynolds, C. J., et al.
Publicado: (2018)

SARS-CoV-2 variants: Subversion of antibody response and predicted impact on T cell recognition
por: Altmann, Daniel M., et al.
Publicado: (2021)

Increased HLA-E expression in white matter lesions in multiple sclerosis
por: Durrenberger, Pascal F, et al.
Publicado: (2012)

Impact of HLA Polymorphism on the Immune Response to Bacillus Anthracis Protective Antigen in Vaccination versus Natural Infection
por: Ascough, Stephanie, et al.
Publicado: (2022)

Exposure of an occluded hemagglutinin epitope drives selection of a class of cross-protective influenza antibodies
por: Adachi, Yu, et al.
Publicado: (2019)

Anthrax Lethal Factor as an Immune Target in Humans and Transgenic Mice and the Impact of HLA Polymorphism on CD4(+) T Cell Immunity
por: Ascough, Stephanie, et al.
Publicado: (2014)

Elongated TCR alpha chain CDR3 favors an altered CD4 cytokine profile
por: Reynolds, Catherine, et al.
Publicado: (2014)

The Evolutionary Selective Advantage of HIV-1 Escape Variants and the Contribution of Escape to the HLA-Associated Risk of AIDS Progression
por: Asquith, Becca
Publicado: (2008)

Natural cutaneous anthrax infection, but not vaccination, induces a CD4(+) T cell response involving diverse cytokines
por: Ingram, Rebecca J, et al.
Publicado: (2015)

Risk of SARS-CoV-2 reinfection after natural infection
por: Boyton, Rosemary J, et al.
Publicado: (2021)

Waning immunity to SARS-CoV-2: implications for vaccine booster strategies
por: Altmann, Daniel M, et al.
Publicado: (2021)

Vaccine efficacy and immune interference: co-administering COVID-19 and influenza vaccines
por: Altmann, Daniel M, et al.
Publicado: (2022)

The immunology of asymptomatic SARS-CoV-2 infection: what are the key questions?
por: Boyton, Rosemary J., et al.
Publicado: (2021)

SARS-Cov-2 immune waning and reinfection in care-home settings
por: Altmann, Daniel M, et al.
Publicado: (2021)

Redirected vaccine imprinting by co-administration of COVID-19 and influenza vaccines
por: Boyton, Rosemary J., et al.
Publicado: (2023)

Imprinted hybrid immunity against XBB reinfection
por: Boyton, Rosemary J, et al.
Publicado: (2023)

Modified ELISPOT: Modifications of the Elispot Assay for T Cell Monitoring in Cancer Vaccine Trials
por: Malyguine, Anatoli
Publicado: (2005)

HLA Class I Binding of HBZ Determines Outcome in HTLV-1 Infection
por: MacNamara, Aidan, et al.
Publicado: (2010)

Canonical and Cross-reactive Binding of NK Cell Inhibitory Receptors to HLA-C Allotypes Is Dictated by Peptides Bound to HLA-C
por: Sim, Malcolm J. W., et al.
Publicado: (2017)

Identification of proliferative and non-proliferative subpopulations of leukemic cells in CLL
por: Cuthill, Kirsty M., et al.
Publicado: (2022)

Identification of Class I HLA T Cell Control Epitopes for West Nile Virus
por: Kaabinejadian, Saghar, et al.
Publicado: (2013)

Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2
por: McDonald, Ian, et al.
Publicado: (2021)

KIR-HLA interactions extend human CD8(+) T cell lifespan in vivo
por: Zhang, Yan, et al.
Publicado: (2023)

Innate receptors modulating adaptive T cell responses: KIR-HLA interactions and T cell-mediated control of chronic viral infections
por: Mora-Bitria, Laura, et al.
Publicado: (2023)

Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes
por: Sedegah, Martha, et al.
Publicado: (2016)

HLA-DO as the Optimizer of Epitope Selection for MHC Class II Antigen Presentation
por: Poluektov, Yuri O., et al.
Publicado: (2013)

Harmonisation of short-term in vitro culture for the expansion of antigen-specific CD8(+) T cells with detection by ELISPOT and HLA-multimer staining
por: Chudley, Lindsey, et al.
Publicado: (2014)

What policy makers need to know about COVID-19 protective immunity
por: Altmann, Daniel M, et al.
Publicado: (2020)

Response definition criteria for ELISPOT assays revisited
por: Moodie, Z., et al.
Publicado: (2010)

Hepitopes: A live interactive database of HLA class I epitopes in hepatitis B virus
por: Lumley, Sheila, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_q604512mbojch2edc3iquktfre